These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
43 related articles for article (PubMed ID: 1657382)
1. Identification of a basal promoter for the human Mr 72,000 type IV collagenase gene and enhanced expression in a highly metastatic cell line. Templeton NS; Stetler-Stevenson WG Cancer Res; 1991 Nov; 51(22):6190-3. PubMed ID: 1657382 [TBL] [Abstract][Full Text] [Related]
2. Independent expression and cellular processing of Mr 72,000 type IV collagenase and interstitial collagenase in human tumorigenic cell lines. Brown PD; Levy AT; Margulies IM; Liotta LA; Stetler-Stevenson WG Cancer Res; 1990 Oct; 50(19):6184-91. PubMed ID: 2169338 [TBL] [Abstract][Full Text] [Related]
3. Stimulation of the 92-kD type IV collagenase promoter and enzyme expression in human melanoma cells. Lauricella-Lefebvre MA; Castronovo V; Sato H; Seiki M; French DL; Merville MP Invasion Metastasis; 1993; 13(6):289-300. PubMed ID: 7860222 [TBL] [Abstract][Full Text] [Related]
4. An Inr-containing sequence flanking the TATA box of the human c-sis (PDGF-B) proto-oncogene promoter functions in cis as a co-activator for its intronic enhancer. Franklin GC; Adam GI; Miller SJ; Moncrieff CL; Ullerås E; Ohlsson R Oncogene; 1995 Nov; 11(9):1873-84. PubMed ID: 7478617 [TBL] [Abstract][Full Text] [Related]
5. Adenovirus E1A represses protease gene expression and inhibits metastasis of human tumor cells. Frisch SM; Reich R; Collier IE; Genrich LT; Martin G; Goldberg GI Oncogene; 1990 Jan; 5(1):75-83. PubMed ID: 2157183 [TBL] [Abstract][Full Text] [Related]
6. Increased expression of the Mr 72,000 type IV collagenase in human colonic adenocarcinoma. Levy AT; Cioce V; Sobel ME; Garbisa S; Grigioni WF; Liotta LA; Stetler-Stevenson WG Cancer Res; 1991 Jan; 51(1):439-44. PubMed ID: 1846313 [TBL] [Abstract][Full Text] [Related]
7. Cloning and characterization of human tumor cell interstitial collagenase. Templeton NS; Brown PD; Levy AT; Margulies IM; Liotta LA; Stetler-Stevenson WG Cancer Res; 1990 Sep; 50(17):5431-7. PubMed ID: 2167156 [TBL] [Abstract][Full Text] [Related]
8. Expression of collagenase IV (basement membrane collagenase) activity in murine tumor cell hybrids that differ in metastatic potential. Turpeenniemi-Hujanen T; Thorgeirsson UP; Hart IR; Grant SS; Liotta LA J Natl Cancer Inst; 1985 Jul; 75(1):99-103. PubMed ID: 2989606 [TBL] [Abstract][Full Text] [Related]
9. AP-1 and C/EBP transcription factors contribute to mda-7 gene promoter activity during human melanoma differentiation. Madireddi MT; Dent P; Fisher PB J Cell Physiol; 2000 Oct; 185(1):36-46. PubMed ID: 10942517 [TBL] [Abstract][Full Text] [Related]
10. Characterization of the promoter region of the rat neprilysin gene. Li C; Hersh LB Arch Biochem Biophys; 1998 Oct; 358(1):189-95. PubMed ID: 9750180 [TBL] [Abstract][Full Text] [Related]
11. Cloning and characterization of the human beta2-glycoprotein I (beta2-GPI) gene promoter: roles of the atypical TATA box and hepatic nuclear factor-1alpha in regulating beta2-GPI promoter activity. Wang HH; Chiang AN Biochem J; 2004 Jun; 380(Pt 2):455-63. PubMed ID: 14984368 [TBL] [Abstract][Full Text] [Related]
12. Analysis of the alpha2C-adrenergic receptor gene promoter and its cell-type-specific activity. Saulnier-Blache JS; Yang Q; Sherlock JD; Lanier SM Mol Pharmacol; 1996 Dec; 50(6):1432-42. PubMed ID: 8967963 [TBL] [Abstract][Full Text] [Related]
13. Identification and functional characterization of the human and murine polo-like kinase (Plk) promoter. Bräuninger A; Strebhardt K; Rübsamen-Waigmann H Oncogene; 1995 Nov; 11(9):1793-800. PubMed ID: 7478607 [TBL] [Abstract][Full Text] [Related]
14. Inhibition of tumor cell invasion by a highly conserved peptide sequence from the matrix metalloproteinase enzyme prosegment. Melchiori A; Albini A; Ray JM; Stetler-Stevenson WG Cancer Res; 1992 Apr; 52(8):2353-6. PubMed ID: 1313744 [TBL] [Abstract][Full Text] [Related]
15. Positive and negative transcriptional elements of the human type IV collagenase gene. Frisch SM; Morisaki JH Mol Cell Biol; 1990 Dec; 10(12):6524-32. PubMed ID: 2174109 [TBL] [Abstract][Full Text] [Related]
16. Modulation of type-IV collagenase activity and invasive behavior of metastatic human melanoma (A2058) cells in vitro by monoclonal antibodies to type-IV collagenase. Höyhtyä M; Hujanen E; Turpeenniemi-Hujanen T; Thorgeirsson U; Liotta LA; Tryggvason K Int J Cancer; 1990 Aug; 46(2):282-6. PubMed ID: 2166712 [TBL] [Abstract][Full Text] [Related]
17. Transcriptional analysis of the mts1 gene with specific reference to 5' flanking sequences. Tulchinsky E; Ford HL; Kramerov D; Reshetnyak E; Grigorian M; Zain S; Lukanidin E Proc Natl Acad Sci U S A; 1992 Oct; 89(19):9146-50. PubMed ID: 1329089 [TBL] [Abstract][Full Text] [Related]
18. Functional analysis of the human calcyclin gene promoter in a panel of human melanoma cell lines. van Groningen JJ; Weterman MA; Swart GW; Bloemers HP Biochem Biophys Res Commun; 1995 Aug; 213(3):1122-31. PubMed ID: 7654229 [TBL] [Abstract][Full Text] [Related]
19. Structure of the mouse 92-kDa type IV collagenase gene. In vitro and in vivo expression in transient transfection studies and transgenic mice. Munaut C; Reponen P; Huhtala P; Kontusaari S; Foidart JM; Tryggvason K Ann N Y Acad Sci; 1994 Sep; 732():369-71. PubMed ID: 7978811 [No Abstract] [Full Text] [Related]
20. Structure and expression of type IV collagenase genes. Tryggvason K; Huhtala P; Tuuttila A; Chow L; Keski-Oja J; Lohi J Cell Differ Dev; 1990 Dec; 32(3):307-12. PubMed ID: 1965956 [No Abstract] [Full Text] [Related] [Next] [New Search]